How can i get keytruda at a reduced cost?

Keytruda, also known as pembrolizumab, is a prescription medication used to treat various types of cancer, including melanoma, non-small cell lung cancer, and others [1]. If you're looking to get Keytruda at a reduced cost, here are some options you can consider:

Affordable Medication Programs: Some pharmaceutical companies, including Merck, the manufacturer of Keytruda, offer patient assistance programs (PAPs) to help make their medications more affordable. These programs often provide financial assistance, copay cards, or free medication to eligible patients [2].

Insurance Discounts and Negotiation: You can ask your healthcare provider or pharmacist about any available discounts or negotiation options with insurance companies. They may be able to lower the copay or negotiate a lower payment with the pharmacy [3].

Generic or Biosimilar Options: It's worth noting that a biosimilar version of Keytruda, called Mvasi, is available on the market. Biosimilars are similar to biologics like Keytruda but are often priced lower [4]. However, not all insurance plans cover biosimilars, so it's essential to check your coverage before switching.

Patient Advocacy Groups: Organizations like the Patient Access Network Foundation (PANF) and the National Patient Advocate Foundation (NPAF) provide financial assistance and advocacy services for patients with high medical expenses, including those using Keytruda [5].

Government Assistance Programs: If you're uninsured or underinsured, you may be eligible for government assistance programs like Medicaid or the Veterans Administration (VA) if you're a veteran [6].

According to DrugPatentWatch.com [7], the patent for Keytruda is expected to expire in 2025. This may lead to increased competition and potentially lower prices in the future.

It's essential to consult with your healthcare provider or a patient advocate to explore all available options and determine the best course of action for your specific situation.

Sources:
[1] - Keytruda (pembrolizumab) [package insert]. Whitehouse Station, NJ: Merck & Co., Inc.
[2] - Merck (2022) Keytruda (pembrolizumab) Patient Assistance Program
[3] - Healthcare Bluebook (2022) How to Negotiate with Your Pharmacy
[4] - Mvasi (biosimilar to Keytruda) [package insert]. Princeton, NJ: Amgen
[5] - PANF (2022) Financial Assistance
[6] - VA (2022) Healthcare Benefits
[7] - DrugPatentWatch.com Keytruda (pembrolizumab) Patent Expiration Date.